ArticleCureus2025
Clinically Isolated IgG4-Related Disease of the Larynx: A Rare Cause of Progressive Dysphonia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immunoglobulin G4 (IgG4)-related disease (IgG4-RD) is a systemic immune-mediated fibroinflammatory condition marked by lesions with dense IgG4-positive plasma cell infiltrates. While it is commonly associated with salivary and pancreatic involvement, isolated laryngeal involvement is extremely rare, with an estimated 15 documented cases. This report describes the case of a 66-year-old female presenting with persistent dysphonia who was found to have isolated IgG4-RD of the larynx, highlighting the diagnostic complexity and novel presentation. The patient presented to the primary care office with persistent and progressive dysphonia following an upper respiratory infection. Laryngoscopy demonstrated a supraglottic submucosal mass. Biopsy showed chronic inflammation, fibrosis, and squamous metaplasia without dysplasia. She was later referred to a tertiary facility for further investigation due to the progressive nature of her symptoms and concern for airway compromise. At that time, the prior biopsy specimen underwent immunohistochemical review for the first time. Immunohistochemical analysis revealed dense lymphoplasmacytic infiltration, storiform fibrosis, and abundant IgG4-positive plasma cells, establishing the diagnosis of IgG4-RD of the larynx. She was initiated on systemic corticosteroids and transitioned to long-term azathioprine, resulting in symptomatic improvement and regression of the laryngeal findings. IgG4-RD of the larynx is a rare manifestation that can be challenging to diagnose. This report emphasizes the importance of immunohistochemical evaluation in patients whose biopsy results are nondiagnostic. Early recognition of IgG4-RD enables timely treatment, reduces the risk of airway compromise, and helps preserve laryngeal function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.